BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Heart
,
Alcohol
,
Ciprofibrate
,
rs2300478
,
PPARA
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gene rearrangement, b- lymphocyte, heavy chain
Summary
General Info
Curated Studies
Most Correlated Studies
PBMCs from B-cell chronic lymphocytic leukemia with or without mutant Ig heavy chain
Progenitor B cells with specific CNOT3 knockout
BCR-ABL1 kinase activity in Philadelphia chromosome positive acute lymphoblastic leukemia (ALL)
Gene expression under different levels of IL-7 & after rescue of genetic defect
Explore Curated Studies Results
Literature
Most Relevant Literature
Long-term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemia.
Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis.
Miliarial-type perifollicular B-cell pseudolymphoma (lymphocytoma cutis): a misleading eruption in t…
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy varia…
Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymph…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymp…
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leuke…
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ